Literature DB >> 30787431

Correction: Bone marrow MSCs in MDS: contribution towards dysfunctional hematopoiesis and potential targets for disease response to hypomethylating therapy.

Zhiyong Poon1, Niraja Dighe1, Subhashree S Venkatesan1, Alice M S Cheung1, Xiubo Fan2, Sudipto Bari1, Monalisa Hota3, Sujoy Ghosh3, William Y K Hwang4,5,6.   

Abstract

In the original version of this article there was a mistake in the spelling of the author Sujoy Ghosh, originally spelt Sujoy Gosh. This has now been corrected in both the PDF and HTML versions of the article.

Entities:  

Year:  2019        PMID： 30787431      PMCID： PMC6756053          DOI： 10.1038/s41375-019-0406-z

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


Correction to: Leukemia; 10.1038/s41375-018-0310-y; published online: 21 December 2018. In the original version of this article there was a mistake in the spelling of the author Sujoy Ghosh, originally spelt Sujoy Gosh. This has now been corrected in both the PDF and HTML versions of the article.
  2 in total

1.  hUC-MSCs: evaluation of acute and long-term routine toxicity testing in mice and rats.

Authors:  Jianwei Xu; Gang Liu; Xianyao Wang; Ya'nan Hu; Hongyang Luo; Lan Ye; Zhanhui Feng; Chen Li; Menglan Kuang; Lijuan Zhang; Yixia Zhou; Xiaolan Qi
Journal:  Cytotechnology       Date:  2022-01-05       Impact factor: 2.058

2.  Mesenchymal stromal cells shape the MDS microenvironment by inducing suppressive monocytes that dampen NK cell function.

Authors:  Dhifaf Sarhan; Jinhua Wang; Upasana Sunil Arvindam; Caroline Hallstrom; Michael R Verneris; Bartosz Grzywacz; Erica Warlick; Bruce R Blazar; Jeffrey S Miller
Journal:  JCI Insight       Date:  2020-03-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.